Thomas A. Kerr, Nicholas O. Davidson – 31 October 2012

Naoki Tanaka, Frank J. Gonzalez – 31 October 2012

Sara Toffanin, Helena Cornella, Andrew Harrington, Josep M. Llovet – 31 October 2012

Gyongyi Szabo, Shashi Bala – 30 October 2012

Austin Duffy, Julia Wilkerson, Tim F. Greten – 30 October 2012 – The presence of cirrhosis increases the potential risk of hemorrhage for patients with hepatocellular carcinoma (HCC). We evaluated the relative risk for hemorrhage in patients with HCC treated with antiangiogenic agents. We performed a systematic review and meta‐analysis of antiangiogenic studies in HCC from 1995 to 2011. For nonrandomized studies we compared bleeding risk with other HCC single‐arm studies that did not include an antiangiogenic agent.

Sean R.R. Hall, Alexander Pedroza‐Gonzalez, Qiuwei Pan, Hugo W. Tilanus, Jeroen de Jonge, Gerard Wagemaker, Luc J.W. van der Laan – 30 October 2012

Arthur Y. Kim, Ellen H. Nagami, Christopher E. Birch, Melinda J. Bowen, Georg M. Lauer, Barbara H. McGovern – 30 October 2012 – Acute hepatitis C virus (HCV) infection is underdiagnosed because most patients are asymptomatic. The majority of new infections occur among people who inject drugs (PWID), many of whom have a history of incarceration. In a previous pilot study, we identified symptomatic HCV cases, mainly among Caucasian inmates.

Carlos J. Pirola, Tomas Fernández Gianotti, Gustavo O. Castaño, Silvia Sookoian – 30 October 2012

Domenico Sansonno, Sabino Russi, Vincenza Conteduca, Loredana Sansonno – 30 October 2012

Xiaolei Shi, Viviana Moroso, Herold J. Metselaar, Jaap Kwekkeboom – 30 October 2012